{{Infobox_gene}}
'''血管活性腸肽'''（{{lang|en|Vasoactive intestinal peptide}}），常見稱'''VIP'''，屬於一種可促進腸道{{tsl|en|vasoactive|血管活性|}}的[[肽类激素|肽类激素]]，由28個[[氨基酸|氨基酸]][[殘基|殘基]]組成。本蛋白屬於升糖素/胰泌素{{tsl|en|protein superfamily|蛋白質超家族|超家族}}，為第二型[[G蛋白偶联受体|G蛋白偶联受体]]的[[配體_(生物化學)|配體]]<ref>{{cite journal | vauthors = Umetsu Y, Tenno T, Goda N, Shirakawa M, Ikegami T, Hiroaki H | title = Structural difference of vasoactive intestinal peptide in two distinct membrane-mimicking environments | journal = Biochimica et Biophysica Acta | volume = 1814 | issue = 5 | pages = 724–30 | date = May 2011 | pmid = 21439408 | doi = 10.1016/j.bbapap.2011.03.009 }}</ref>。VIP在許多[[脊椎動物|脊椎動物]]身上皆存在，包含{{tsl|en|Gut (zoology)|腸 (動物學)|腸}}、[[胰脏|胰脏]]，以及[[下視丘|下視丘]]{{tsl|en|suprachiasmatic nuclei|視上核}}<ref>{{cite journal | vauthors = Juhász T, Helgadottir SL, Tamás A, Reglődi D, Zákány R | title = PACAP and VIP signaling in chondrogenesis and osteogenesis | journal = Peptides | volume = 66 | pages = 51–7 | date = April 2015 | pmid = 25701761 | doi = 10.1016/j.peptides.2015.02.001 }}</ref><ref>{{cite journal | vauthors = Delgado M, Ganea D | title = Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions | journal = Amino Acids | volume = 45 | issue = 1 | pages = 25–39 | date = July 2013 | pmid = 22139413 | pmc = 3883350 | doi = 10.1007/s00726-011-1184-8 }}</ref><ref>{{cite journal | vauthors = Fahrenkrug J | title = VIP and PACAP | journal = Results and Problems in Cell Differentiation | volume = 50 | pages = 221–34 | date = 2010-01-01 | pmid = 19859678 | doi = 10.1007/400_2009_24 }}</ref>。VIP能刺激心臟{{tsl|en|contractility|收縮力}}、[[血管舒張|血管舒張]]、增加[[糖原分解|糖原分解]]、降低動脈[[血壓|血壓]]，以及促進[[氣管|氣管]]、胃、[[膽囊|膽囊]]平滑肌舒張。在人類體內，該蛋白的編碼基因為「''VIP''」<ref>{{cite journal | vauthors = Hahm SH, Eiden LE | title = Cis-regulatory elements controlling basal and inducible VIP gene transcription | journal = Annals of the New York Academy of Sciences | volume = 865 | pages = 10–26 | date = December 1998 | pmid = 9927992 }}</ref>

VIP在血中的[[半衰期|半衰期]]（t<sub>½</sub>）約兩分鐘<ref>{{cite journal | vauthors = Henning RJ, Sawmiller DR | title = Vasoactive intestinal peptide: cardiovascular effects | journal = Cardiovascular Research | volume = 49 | issue = 1 | pages = 27–37 | date = January 2001 | pmid = 11121793 }}</ref>。

== 參考文獻 ==
* {{tsl|en|Vasoactive intestinal peptide receptor|血管活性腸肽受體}}
* {{tsl|en|VIPR1|VPAC1}}
* {{tsl|en|VIPR2|VPAC2}}

== 參考文獻 ==
{{Reflist|33em}}

== 延伸閱讀 ==
{{refbegin|33em}}
* {{cite journal|last1=Watanabe|first1=Jun | name-list-format = vanc | title = Subchapter 18E - Vasoactive Intestinal Peptide|journal=Handbook of Hormones | date = 1 January 2016 | pages = 150–e18E-10 | doi = 10.1016/b978-0-12-801028-0.00146-x | publisher=Academic Press}}
* {{cite journal | vauthors = Fahrenkrug J | title = Gut/brain peptides in the genital tract: VIP and PACAP | journal = Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum | volume = 234 | issue =  | pages = 35–9 | year = 2001 | pmid = 11713978 }}
* {{cite journal | vauthors = Delgado M, Pozo D, Ganea D | title = The significance of vasoactive intestinal peptide in immunomodulation | journal = Pharmacological Reviews | volume = 56 | issue = 2 | pages = 249–90 | date = June 2004 | pmid = 15169929 | doi = 10.1124/pr.56.2.7 }}
* {{cite journal | vauthors = Conconi MT, Spinazzi R, Nussdorfer GG | title = Endogenous ligands of PACAP/VIP receptors in the autocrine-paracrine regulation of the adrenal gland | journal = International Review of Cytology | volume = 249 | issue =  | pages = 1–51 | year = 2006 | pmid = 16697281 | doi = 10.1016/S0074-7696(06)49001-X | isbn = 978-0-12-364653-8 }}
* {{cite journal | vauthors = Hill JM | title = Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential | journal = Current Pharmaceutical Design | volume = 13 | issue = 11 | pages = 1079–89 | year = 2007 | pmid = 17430171 | doi = 10.2174/138161207780618975 }}
* {{cite journal | vauthors = Gonzalez-Rey E, Varela N, Chorny A, Delgado M | title = Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator | journal = Current Pharmaceutical Design | volume = 13 | issue = 11 | pages = 1113–39 | year = 2007 | pmid = 17430175 | doi = 10.2174/138161207780618966 }}
* {{cite journal | vauthors = Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, Hill JM | title = Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist | journal = Brain Research | volume = 570 | issue = 1-2 | pages = 49–53 | date = January 1992 | pmid = 1617429 | doi = 10.1016/0006-8993(92)90562-n }}
* {{cite journal | vauthors = Theriault Y, Boulanger Y, St-Pierre S | title = Structural determination of the vasoactive intestinal peptide by two-dimensional H-NMR spectroscopy | journal = Biopolymers | volume = 31 | issue = 4 | pages = 459–64 | date = March 1991 | pmid = 1863695 | doi = 10.1002/bip.360310411 }}
* {{cite journal | vauthors = Gozes I, Giladi E, Shani Y | title = Vasoactive intestinal peptide gene: putative mechanism of information storage at the RNA level | journal = Journal of Neurochemistry | volume = 48 | issue = 4 | pages = 1136–41 | date = April 1987 | pmid = 2434617 | doi = 10.1111/j.1471-4159.1987.tb05638.x }}
* {{cite journal | vauthors = Yamagami T, Ohsawa K, Nishizawa M, Inoue C, Gotoh E, Yanaihara N, Yamamoto H, Okamoto H | title = Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter | journal = Annals of the New York Academy of Sciences | volume = 527 | issue =  | pages = 87–102 | year = 1988 | pmid = 2839091 | doi = 10.1111/j.1749-6632.1988.tb26975.x }}
* {{cite journal | vauthors = DeLamarter JF, Buell GN, Kawashima E, Polak JM, Bloom SR | title = Vasoactive intestinal peptide: expression of the prohormone in bacterial cells | journal = Peptides | volume = 6 Suppl 1 | issue = Suppl 1 | pages = 95–102 | year = 1985 | pmid = 2995945 | doi = 10.1016/0196-9781(85)90016-6 }}
* {{cite journal | vauthors = Linder S, Barkhem T, Norberg A, Persson H, Schalling M, Hökfelt T, Magnusson G | title = Structure and expression of the gene encoding the vasoactive intestinal peptide precursor | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 84 | issue = 2 | pages = 605–9 | date = January 1987 | pmid = 3025882 | pmc = 304259 | doi = 10.1073/pnas.84.2.605 }}
* {{cite journal | vauthors = Gozes I, Bodner M, Shani Y, Fridkin M | title = Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor | journal = Peptides | volume = 7 Suppl 1 | issue = Suppl 1 | pages = 1–6 | year = 1986 | pmid = 3748844 | doi = 10.1016/0196-9781(86)90156-7 }}
* {{cite journal | vauthors = Tsukada T, Horovitch SJ, Montminy MR, Mandel G, Goodman RH | title = Structure of the human vasoactive intestinal polypeptide gene | journal = Dna | volume = 4 | issue = 4 | pages = 293–300 | date = August 1985 | pmid = 3899557 | doi = 10.1089/dna.1985.4.293 }}
* {{cite journal | vauthors = Heinz-Erian P, Dey RD, Flux M, Said SI | title = Deficient vasoactive intestinal peptide innervation in the sweat glands of cystic fibrosis patients | journal = Science | volume = 229 | issue = 4720 | pages = 1407–8 | date = September 1985 | pmid = 4035357 | doi = 10.1126/science.4035357 }}
{{refend}}

== 外部連結 ==
* [http://www.biocarta.com/pathfiles/vipPathway.gif Pathway at biocarta.com]
* {{GeorgiaPhysiology|6/6ch2/s6ch2_34}}

{{Hormones}}
{{Neuropeptides}}

[[Category:肽类激素|Category:肽类激素]]
[[Category:消化系统激素|Category:消化系统激素]]
[[Category:下視丘激素|Category:下視丘激素]]